Philippe Weigerstorfer
Director/Board Member at SONOMA PHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Profile
Philippe Weigerstorfer is currently the Chairman at Onycho Pharma Pte Ltd.
and an Independent Director at Sonoma Pharmaceuticals, Inc. He previously served as the Executive Chairman at Galenica AG from 2000 to 2016, Managing Director at Vifor Pharma Asia Pacific Pte Ltd.
from 2011 to 2017, and Head of Corporate Development Division at Vifor Pharma AG from 1999 to 2011.
He also held positions at Novartis AG and Sandoz Pharmaceuticals AG.
Mr. Weigerstorfer received his undergraduate and graduate degrees from the University of Basel.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-07-20 | 0 ( -.--% ) | - $ | 2024-03-30 |
Philippe Weigerstorfer active positions
| Companies | Position | Start |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Director/Board Member | 2018-09-18 |
| Onycho Pharma Pte Ltd. | Chairman | 2019-12-31 |
Former positions of Philippe Weigerstorfer
| Companies | Position | End |
|---|---|---|
| Vifor Pharma Asia Pacific Pte Ltd. | Chief Executive Officer | 2016-12-31 |
| GALENICA AG | Chairman | 2015-12-31 |
| VIFOR PHARMA | Corporate Officer/Principal | 2011-06-30 |
| NOVARTIS AG | Corporate Officer/Principal | 1998-12-31 |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Corporate Officer/Principal | - |
Training of Philippe Weigerstorfer
| University of Basel | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| SONOMA PHARMACEUTICALS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| GALENICA AG | Distribution Services |
| Private companies | 5 |
|---|---|
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
| Onycho Pharma Pte Ltd. | |
| Vifor Pharma Asia Pacific Pte Ltd. |
- Stock Market
- Insiders
- Philippe Weigerstorfer
